INSIDE INFORMATION ANNOUNCEMENT LICENSE AND SUPPLY AGREEMENT WITH ORGANON FOR HLX11 (ANTI-HER2 DOMAIN II HUMANISED MONOCLONAL ANTIBODY INJECTION) AND HLX14 (RECOMBINANTLicense and Supply Agreement • September 25th, 2019
Contract Type FiledSeptember 25th, 2019This announcement is made by Shanghai Henlius Biotech, Inc. (the “Company”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571, Laws of Hong Kong).